30% of Adults Depressed; Safety Anxiety Runs High; Reimbursement Woes for ADHD Games

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

Nearly 30% of U.S. adults say they've been diagnosed with depression at some point in their lives -- up 10% since 2015 -- according to a Gallup poll.

The FDA issued updated warnings to improve safe use of prescription stimulants to treat attention deficit-hyperactivity disorder (ADHD) and other conditions.

A new pivotal study testing a once-weekly version of oral risperidone for schizophrenia is now underway, said Lyndra Therapeutics.

In an American Psychiatric Association poll, 70% of adults said they feel anxious about keeping themselves or their families safe. "Even as we end the public health emergency, people remain anxious about their safety," said APA President Rebecca W. Brendel, MD, JD, in a statement.

Addiction treatment, especially for racial minorities, isn't being prescribed nearly enough. (New York Times)

Despite regulatory approval, dozens of new apps and video game therapies for ADHD, insomnia, and opioid use disorder cannot be reimbursed by the Centers for Medicare & Medicaid Services. (Politico)

The University of Washington School of Medicine in Seattle is slated to lead a study testing psilocybin in military veterans and first-responders with post-traumatic stress disorder and alcohol use disorder.

A rural northeastern Tennessee county with the highest national rate of overdose deaths opted to funnel its opioid settlement payout towards things other than addiction treatment programs. (KFF Health News)

Tune in to MedPage Today's Instagram Live addressing adolescent mental health on Thursday, May 18, at 2:00 p.m. ET .

  • author['full_name']

    Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.